Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Atlassian
TEAM
|
$437M |
| 2 |
AbbVie
ABBV
|
$380M |
| 3 |
Workday
WDAY
|
$366M |
| 4 |
Synopsys
SNPS
|
$323M |
| 5 |
Advanced Micro Devices
AMD
|
$286M |
Top Sells
| 1 |
Adobe
ADBE
|
$1.71B |
| 2 |
Apple
AAPL
|
$984M |
| 3 |
Boston Scientific
BSX
|
$642M |
| 4 |
Microsoft
MSFT
|
$599M |
| 5 |
Texas Instruments
TXN
|
$491M |
Sector Composition
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Prologis
PLD
$103B
| $330M | 0.16% |
2,045,397
+39,270
| +2% | +$6.34M |
|
152
Cboe Global Markets
CBOE
$24.6B
| $328M | 0.16% |
2,868,681
+2,105
| +0.1% | +$241K |
|
153
Tesla
TSLA
$1.08T
| $321M | 0.16% |
894,714
-464,727
| -34% | -$167M |
|
154
Elanco Animal Health
ELAN
$8.57B
| $321M | 0.16% |
12,311,871
+715,654
| +6% | +$18.7M |
|
|
BHVN
155
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $321M | 0.15% |
2,706,152
+1,299,597
| +92% | +$154M |
|
156
Estee Lauder
EL
$31.8B
| $318M | 0.15% |
1,165,827
-71,605
| -6% | -$19.5M |
|
157
Gilead Sciences
GILD
$140B
| $316M | 0.15% |
5,315,286
-22,544
| -0.4% | -$1.34M |
|
158
VICI Properties
VICI
$35.6B
| $310M | 0.15% |
10,899,723
-1,588,477
| -13% | -$45.2M |
|
159
Autodesk
ADSK
$67.7B
| $299M | 0.14% |
1,395,486
-1,555,101
| -53% | -$333M |
|
160
Novartis
NVS
$249B
| $297M | 0.14% |
3,380,885
-178,294
| -5% | -$15.6M |
|
161
Tyler Technologies
TYL
$23.9B
| $291M | 0.14% |
653,660
+2,134
| +0.3% | +$949K |
|
162
Corning
GLW
$59.6B
| $290M | 0.14% |
7,860,908
-200,615
| -2% | -$7.4M |
|
163
Centene
CNC
$14B
| $287M | 0.14% |
3,414,610
-181,263
| -5% | -$15.3M |
|
164
West Pharmaceutical
WST
$17.9B
| $283M | 0.14% |
688,398
-190,464
| -22% | -$78.2M |
|
165
Icon
ICLR
$13.7B
| $282M | 0.14% |
1,160,950
-1,184,771
| -51% | -$288M |
|
166
Canadian Natural Resources
CNQ
$65.4B
| $280M | 0.14% |
9,229,452
-1,684,023
| -15% | -$51.1M |
|
167
Cisco
CSCO
$270B
| $280M | 0.14% |
5,023,579
-115,270
| -2% | -$6.43M |
|
168
Snowflake
SNOW
$73.8B
| $279M | 0.13% |
1,217,676
+174,461
| +17% | +$40M |
|
169
Johnson & Johnson
JNJ
$428B
| $275M | 0.13% |
1,554,209
+15,414
| +1% | +$2.73M |
|
170
Unity
U
$16.8B
| $275M | 0.13% |
2,775,196
+506,957
| +22% | +$50.3M |
|
171
AstraZeneca
AZN
$253B
| $274M | 0.13% |
4,134,675
-2,504,400
| -38% | -$166M |
|
172
Regal Rexnord
RRX
$9.65B
| $273M | 0.13% |
1,838,109
-401,955
| -18% | -$59.8M |
|
173
CVS Health
CVS
$93.2B
| $273M | 0.13% |
2,696,863
-548,607
| -17% | -$55.5M |
|
174
Goldman Sachs
GS
$225B
| $271M | 0.13% |
821,021
+375,103
| +84% | +$124M |
|
175
ResMed
RMD
$40B
| $269M | 0.13% |
1,108,015
-216,416
| -16% | -$52.5M |
|